BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12012263)

  • 1. [Disturbances of body-experience in acute anxiety and depressive disorders - neuroticism or somatization?].
    Röhricht F; Beyer W; Priebe S
    Psychother Psychosom Med Psychol; 2002 May; 52(5):205-13. PubMed ID: 12012263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Follow-up study of quality of life and treatment of eating disorder: dynamics of the depressive and anxiety symptoms].
    Banaś A; Januszkiewicz-Grabias A; Radziwiłłowicz P; Smoczyński S
    Psychiatr Pol; 2002; 36(6 Suppl):323-9. PubMed ID: 12647456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relation between anger management style, mood and somatic symptoms in anxiety disorders and somatoform disorders.
    Koh KB; Kim DK; Kim SY; Park JK; Han M
    Psychiatry Res; 2008 Sep; 160(3):372-9. PubMed ID: 18718675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Somatic symptoms of depression].
    Güleç H; Sayar K; Ozkorumak E
    Turk Psikiyatri Derg; 2005; 16(2):90-6. PubMed ID: 15981146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Affective perception of the body in neurotics. Its relation to anxiety, depression, and various types of defense].
    Buxant P
    Acta Psychiatr Belg; 1976 May; 76(3):415-37. PubMed ID: 1020680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subsyndromal depressive symptoms in patients with bipolar and unipolar disorder during clinical remission.
    Vieta E; Sánchez-Moreno J; Lahuerta J; Zaragoza S;
    J Affect Disord; 2008 Apr; 107(1-3):169-74. PubMed ID: 17870184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Body image of patients with acute paranoid schizophrenia. A follow-up study].
    Röhricht F; Priebe S
    Nervenarzt; 1996 Jul; 67(7):602-7. PubMed ID: 8927200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S; Ferreri M; Cabanac F; Bitton M
    Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Social anxiety symptoms across diagnoses among outpatients attending a tertiary care mood and anxiety disorders service.
    Graystone HJ; Garner MJ; Baldwin DS
    J Affect Disord; 2009 Apr; 114(1-3):305-9. PubMed ID: 18656267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression and somatic symptoms scale: a new scale with both depression and somatic symptoms emphasized.
    Hung CI; Weng LJ; Su YJ; Liu CY
    Psychiatry Clin Neurosci; 2006 Dec; 60(6):700-8. PubMed ID: 17109704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pain-related anxiety and anxiety sensitivity across anxiety and depressive disorders.
    Carleton RN; Abrams MP; Asmundson GJ; Antony MM; McCabe RE
    J Anxiety Disord; 2009 Aug; 23(6):791-8. PubMed ID: 19362446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response.
    Jäger M; Riedel M; Schmauss M; Pfeiffer H; Laux G; Naber D; Gaebel W; Huff W; Schmidt LG; Heuser I; Buchkremer G; Kühn KU; Rüther E; Hoff P; Gastpar M; Bottlender R; Strauss A; Möller HJ
    Psychiatry Res; 2008 Apr; 158(3):297-305. PubMed ID: 18280582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The association between disability and residual symptoms in depressive patients: a 3-month follow-up].
    Ozyüksel B; Uluğ B
    Turk Psikiyatri Derg; 2007; 18(4):323-32. PubMed ID: 18066723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric symptoms in clients presenting for commercial weight reduction treatment.
    Goldstein LT; Goldsmith SJ; Anger K; Leon AC
    Int J Eat Disord; 1996 Sep; 20(2):191-7. PubMed ID: 8863072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of anxiety and depression in childhood migraine.
    Braccili T; Montebello D; Verdecchia P; Crenca R; Redondi A; Turri E; Turaccio R; Lendvai D
    Eur Rev Med Pharmacol Sci; 1999; 3(1):37-9. PubMed ID: 10710829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and psychosocial factors of anxiety and depression in breast cancer patients.
    Lueboonthavatchai P
    J Med Assoc Thai; 2007 Oct; 90(10):2164-74. PubMed ID: 18041438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body image and self-esteem in somatizing patients.
    Sertoz OO; Doganavsargil O; Elbi H
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):508-15. PubMed ID: 19531108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.